- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
USV Launches INSUQUICK, First Biosimilar Insulin Aspart in India
Overview
USV Pvt. Ltd, leaders in oral anti-diabetes segment, has announced the launch of 1st biosimilar Insulin Aspart in India, INSUQUICK, for the treatment of people living with Diabetes
INSUQUICK® is DCGI-approved for the management of glycemic control in people living with Diabetes.
INSUQUICK® is available in INSUQUICK® Cartridge, INSUQUICK® vial & INSUQUICK® VDPen.
INSUQUICK® VDPen is a prefilled, disposable variable dose pen injector, featuring a modern robust design, lightweight, large legible scale, and with audible clicks for precise incremental settings.
USV has also announced the launch of USVPen®, a reusable pen designed for USV’s range of insulin. USVPen® delivers accurate dose of insulin with low dose force which makes it user-friendly.
Achieved through relentless R&D efforts of more than 10 years, INSUQUICK® uses 100% indigenous robust technology, guaranteeing complete cold chain care. INSUQUICK® aligns with global regulatory standards, making it a world-class and truly "Made in India" affordable solution.
Insuquick establishes fingerprint-like similarity in efficacy, safety, and immunogenicity profile as compared to Innovator.
Speakers
Dr. Nandita Mohan
BDS, MDS( Pedodontics and Preventive Dentistry)